• HOME
  • RESEARCH
    • Biology and dysregulation of IncRNAs
    • Ribosomopathies
    • Epigenetic engineering
    • Engineering cellular immunotherapies
    • Drugging SARS-CoV2 RNA-protein interactions
    • Funding
  • PUBLICATIONS
  • WHO WE ARE
    • Principal Investigator
    • Members
    • Collaborators
    • Alumni
    • Positions Available
    • Lab News
    • Communities
  • MENTORSHIP
  • ENTREPRENEURSHIP
  • CONTACT US
Novina Lab - Engineering Biological Technologies into Therapies

Welcome Nico!

2/1/2021

0 Comments

 
Nico Müller, a Master’s student from the University of Heidelberg, Germany, joined the Novina lab.
0 Comments

Welcome Felix!

2/1/2021

0 Comments

 
​Felix Faas, a Master student in the Biochemistry Program at the Eberhard-Karls-University of Tübingen, Germany, joined the Novina Lab.
0 Comments

NextRNA Therapeutics launched!

2/1/2021

0 Comments

 
​NextRNA Therapeutics launches; this new company is based on an RNA target and drug discovery platform technology developed in the Novina lab by scientist Leon Wert-Lamas.
0 Comments

Welcome Iggy!

2/1/2021

0 Comments

 
​Iggy Im, an undergraduate student from Boston College, joined the Novina lab.
0 Comments

    Novina Lab News

    Archives

    July 2021
    May 2021
    February 2021
    January 2021
    December 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    March 2020
    January 2020
    December 2019
    September 2019
    July 2019
    January 2019
    October 2018
    September 2018
    August 2018
    July 2018
    May 2018
    April 2018
    March 2018
    January 2018

    Categories

    All
    Funding
    Lab Updates

    RSS Feed

 HOME | RESEARCH | PUBLICATIONS | WHO WE ARE | MENTORSHIP | ENTREPRENEURSHIP | SUPPORT US | CONTACT US

©2017 Novina Lab at Dana-Farber Cancer Institute